|
⚲
|
| Juvaris Bio Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001347758 |
| Sale | 2009-09-11 ($25.1 M Offered, $15.1 M Sold) |
| Fund | |
| Phone | 6506978828 |
| Address | 866 Malcolm Road, Suite 100 Burlingame, 94010 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kimberlee Gonzaga | |
| Michael Ross | |
| Thomas Monath | |
| Grant Pickering | |
| Lewis Williams | |
| Carol Brosgart |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Helfert Adrian
✚
|
0.0 | |
|
Helfrich Austen B.
✚
|
0.0 | |
|
Helgeson Bradford John
✚
|
0.0 | |
|
Helia Care, Inc.
✚
|
0.0 | |
|
Heligenics, Inc.
✚
|
0.0 | |
|
He Linglong
✚
|
0.0 | |
|
Helios Coinvest Fund LP
✚
|
0.0 | |
|
Helios Solar Partners X, LLC
✚
|
0.0 | |
|
Helio Ventures Lambda a Series of Kalea Ventures LLC
✚
|
0.0 | |
|
Helen A. Dolan 2018 Grantor Retained Annuity Trust #1M
✚
|
0.0 |